Company: APXIF
Filing Date: 2025-06-11
Form Type: 10-Q
Source: 0001213900-25-053185
Chunk: 126

Company: APx Acquisition Corp. I
Filing Date: 2025-06-11
Form: 10-Q
Item: Part I, Item 8
Chunk 126
---
 (the “MultiplAI Shareholders”)
of ordinary shares, par value £0.0001, of MultiplAI and any other equity commitments or equity securities of MultiplAI, including
any securities or commitments convertible into, exchangeable or exercisable for, or representing the right to subscribe for, any such
ordinary shares of MultiplAI (such securities, the “MultiplAI Shares”) entered into that certain amended and restated share
purchase agreement (the “MultiplAI SPA”) relating to the sale and purchase of all of the ordinary shares of MultiplAI and,
if required under the MultiplAI SPA, all of the MultiplAI Shareholders’ rights and interest in certain equity related agreements
and convertible securities, as well as any related ancillary documents or agreements.

On August 27, 2024,
Parent, MultiplAI and the MultiplAI Shareholders (with the consent of the Company) terminated the MultiplAI SPA.

Voting and Support Agreement

Concurrently with the
execution of the Business Combination Agreement, the Company, Templar Sponsor, OmnigenicsAI and the Parent entered into a Voting and Support
Agreement (the “Support Agreement”), pursuant to which, among other things, the Templar Sponsor agreed to vote any of the
Sponsor Current Shares (as defined in the Support Agreement) and any SPAC Ordinary Shares held by the Sponsor in favor of the Proposed
Business Combination, and Parent agreed to vote any of the Parent Subject Shares (as defined in the Support Agreement) in favor of the
Proposed Business Combination.

Additionally, the Support
Agreement contains certain covenants to be performed by the parties thereto following the Closing.

The foregoing description
of the Support Agreement is qualified in its entirety by reference to the full text of the Support Agreement, a copy of which is included
as an exhibit to this Quarterly Report.

 35

Backstop Agreement

Concurrently with the
execution of the Business Combination Agreement, Theo I SCSp, a special limited partnership (société en commandite spéciale)
governed by the laws of the Grand Duchy of Luxembourg and a shareholder of Parent (“Theo”), OmnigenicsAI and the Company entered
into the Backstop Agreement, pursuant to which, among other things, subject to and conditioned upon the occurrence of the Closing, Theo
shall be obligated to obtain the amount (if any) by which $10,000,000 exceeds the aggregate amount of cash on deposit in